Stocks Swing, Continuing Worst Week in Years
The stock market rout refused to abate Friday, as the Dow industrials extended losses in afternoon trading, on pace for its biggest one-week drop since the throes of the financial crisis.
Trump Signs Budget Deal, Stopgap Spending Bill to End Shutdown
President Donald Trump signed a two-year budget deal Friday morning, along with a stopgap spending bill to end a brief government shutdown, hours after the House narrowly passed the measure.
EU's Chief Negotiator Throws Doubt on Quick Brexit Deal
"Substantial" differences exist between the U.K. and the European Union on the terms of a post-Brexit transition agreement, the EU's chief negotiator said, throwing further doubt on hopes for a quick deal.
Why Boring Is No Longer Beautiful in Stocks
Popular defensive strategies aren't working so well in a rising interest-rate environment.
Appeals Court Exempts Loan Funds from Dodd-Frank Risk-Retention Rule
Managers of Wall Street funds that lend money to heavily indebted firms won't have to retain an interest in the debt they sell to investors after a federal appeals court invalidated part of a major postcrisis rule.
China Signs First Long-Term Deal for U.S. Natural Gas
China has signed its first long-term contract to import U.S. liquefied natural gas, following a push by the Trump administration to open the rapidly growing market to U.S. suppliers.
As Inflation Fears Roil Markets, Firms Face New Pressure to Raise Prices
U.S. manufacturers and food companies are grappling with rising material costs on top of pressure from higher wages-a potential double whammy that could force them to raise prices or accept lower profit margins.
Flu Fears Halt a Long Decline in Orange Juice Sales
It took one of the worst flu seasons on record to get more Americans guzzling orange juice again. Orange juice sales rose 0.9% in the four weeks ended Jan. 20, marking the first year-over-year increase in nearly five years.
Trump Moves to Cut Costs for Prescription Drugs
The Trump administration is backing a set of actions aimed at lowering prescription-drug costs, including a cap on the dollar amount that American seniors pay each year for expensive prescription drugs.
Is It Finally Time to Worry About Junk ETFs?
The largest exchange-traded junk bond and bank loan funds have fallen to discounts to the value of their assets rarely seen since the products first became popular four years ago.